
Hormones & Methylation
Metabolism & Thyroid
Cardiovascular
Nutrients
Inflammation
Genetic Heart Risk
Growth & Repair Marker
Thyroid Function
Intercellular Magnesium
Iron Storage
Fertility Signaling
Systemic Inflammation Marker
GHK-Cu
BPC-157
TB 500
MOTS-C
Sermorlin
Ipamorelin
CJC-1295
Semax & Selank
Thymulin
Detoxification Capacity
Neurotransmitter Production
Folate Metabolism
Cardiovascular Risk
Stroke and Heart Attack Risk
Cellular B12 Deficiency
Methylation Gene Variant
Detoxification Capacity
Neurotransmitter Production
Folate Metabolism
Cardiovascular Risk
Cellular B12 Deficiency
Gut Bacteria
Methylation Gene Variant
Morning Stress Hormone
Mood, Libido, Energy
Metabolism via Thyroid
Metabolism via Insulin
Sperm Production
Growth Factor Levels
Pituitary Function
Particle Analysis
Genetic Cardiac Risk Markers
Toxic Metal Exposure
Gut-Heart Axis Testing
Detox Protocol
Environmental Toxins
Fat Burning Hormone Level
Real-Time Sugar Control
Gout and Metabolic
Lipid Genetics
Monitor Testosterone Levels
Adjust TRT Medication Dose
Monitor Blood Volume
Monitor Blood Thickness
Prostate Safety
Kidney & Hydration
Liver & Cholesterol
Baseline Before Weight Loss
Check Inflammation
Metabolism via Slow Thyroid
Observe Insulin Resistance
Fat-Burning Hormone
Organ Function
Gout & Thyroid
Plaque Build Up in Arteries
Inflammation
Clotting Risk
Cholesterol Particle Size
Gut-Produced Toxins
Genetic Heart Risk
Check Feeling Cold & Tired
Explain Weight Gain
Autoimmune attacks Thyroid
Stress Hormones Blocking Metabolism
Inflammation Destroying Gut
Gluten Reaction
Yeast Overgrowth
Bloating vs Stress
Toxic Metals
Brain Fog
Fatigue
Baseline Before Detox
Gut-Produced Toxins
Nutrient Gap
Cause of Fatigue & Brain Fog
Mineral Imbalances
Unbalanced Omega Fatty Acid
Cause of Inflammation
Liver Function
Kidney Status
Blood Sugar Levels
Anemia
Infection & Immune Function
Cholesterol Levels
Thyroid Activity
Cholesterol
Low Libido
Erectile Issues
Early Prostate Check
Metabolism Issues
Muscle Mass
Growth & Repair Marker
Every biomarker explained: what it measures, why it matters, reference ranges, and evidence-based interventions. Reviewed by Ahmed Mahdi, DNP.
1,5-Anhydroglucitol (1,5-AG) is a naturally occurring monosaccharide that competes with glucose for renal reabsorption. When blood glucose spikes above the renal threshold (~180 mg/dL), glucose displaces 1,5-AG in the kidneys, causing 1,5-AG to be excreted in urine and its blood levels to drop. This makes it a sensitive, real-time marker of glycemic variability and glucose excursions.
1,5-AG detects glucose spikes that HbA1c completely misses. A patient can have a normal HbA1c (good average) yet experience damaging postprandial glucose spikes that 1,5-AG reveals. It is the best blood marker for glycemic variability — a key driver of oxidative stress, endothelial damage, and diabetic complications.
| Measure | Quest Diagnostics Range | Optimal / Functional Range |
|---|---|---|
| 1,5-Anhydroglucitol | 10.7 – 32.0 mcg/mL (males) | > 14 μg/mL |
Recent glucose excursions and spikes (even if HbA1c is normal), poor glycemic control, prediabetes with postprandial hyperglycemia, and increased oxidative stress. Lower 1,5-AG correlates with greater glucose variability.
Adiponectin is a protein hormone secreted by adipose (fat) tissue that plays a protective role in metabolic health. Unlike most adipokines, adiponectin levels are inversely related to body fat — the leaner and more metabolically healthy you are, the higher your adiponectin. It enhances insulin sensitivity, reduces inflammation, and protects blood vessel walls from atherosclerosis.
Adiponectin is a powerful predictor of metabolic syndrome, type 2 diabetes, and cardiovascular disease risk. Low levels indicate visceral adiposity and insulin resistance even when BMI appears normal.
| Measure | Quest Diagnostics Range | Optimal / Functional Range |
|---|---|---|
| Adiponectin (males) | 4 – 26 mcg/mL | 10 – 20 μg/mL |
Obesity (especially visceral), metabolic syndrome, insulin resistance, type 2 diabetes risk, cardiovascular disease risk, non-alcoholic fatty liver disease, and chronic low-grade inflammation.
Generally protective and associated with leanness, insulin sensitivity, and reduced cardiovascular risk.
Apolipoprotein B is the primary structural protein on all atherogenic lipoprotein particles — including LDL, VLDL, IDL, and Lp(a). Each atherogenic particle carries exactly one ApoB molecule, making ApoB a direct count of the total number of particles that can penetrate the arterial wall and drive atherosclerosis. It is increasingly regarded as the single best lipid marker for cardiovascular risk.
ApoB is superior to LDL cholesterol for predicting cardiovascular risk because it measures particle number rather than cholesterol content. Two patients with identical LDL-C levels can have vastly different ApoB levels (and therefore different risk profiles), particularly in the setting of insulin resistance, metabolic syndrome, or diabetes where small dense LDL particles predominate.
| Measure | Quest Diagnostics Range | Optimal / Functional Range |
|---|---|---|
| ApoB | < 130 mg/dL | < 80 mg/dL (some experts recommend < 60 mg/dL) |
Increased number of atherogenic particles, elevated cardiovascular and stroke risk, often discordant with LDL-C (ApoB may be high even when LDL appears normal). Associated with insulin resistance, metabolic syndrome, familial hypercholesterolemia, and high dietary saturated fat intake.
Apolipoprotein E (ApoE) is a protein involved in cholesterol transport and metabolism, particularly the clearance of triglyceride-rich lipoproteins from the bloodstream. The ApoE gene has three common alleles — E2, E3, and E4 — producing six possible genotype combinations. This is a one-time genetic test.
ApoE genotype influences lipid metabolism, Alzheimer's disease risk, and cardiovascular risk. It guides dietary and pharmacological decisions: E4 carriers may respond more dramatically to dietary saturated fat, may benefit from earlier statin use, and carry increased Alzheimer's risk requiring proactive neuroprotective strategies.
| Genotype | Lipid Impact | Clinical Significance |
|---|---|---|
| E2/E2 | Lowest LDL, highest triglycerides | Type III hyperlipoproteinemia risk |
| E3/E3 | Most common, "normal" metabolism | Standard lipid metabolism |
| E3/E4 or E4/E4 | Higher LDL, enhanced fat absorption | Increased Alzheimer's and cardiovascular risk |
E4 carriers (approximately 25% of the population) have increased LDL cholesterol, enhanced intestinal fat absorption, impaired amyloid-beta clearance in the brain (Alzheimer's risk), and greater sensitivity to dietary saturated fat. E4/E4 homozygotes carry 10–15x increased Alzheimer's risk.
Arsenic is a naturally occurring metalloid found in soil and groundwater. Chronic low-level exposure — primarily through rice, drinking water, and pesticides — causes oxidative stress and DNA damage at the cellular level.
To identify chronic environmental arsenic exposure, which is linked to increased cardiovascular disease, diabetes, and cancer risk.
| Category | Value (mcg/L) | Interpretation |
|---|---|---|
| Normal | <23 | No significant exposure |
| Elevated | 23–50 | Above-average exposure; identify sources |
| High | >50 | Significant exposure; intervention needed |
Normal levels indicate no significant arsenic burden. No intervention needed.
Fatigue, GI disturbances, peripheral neuropathy, skin changes (hyperpigmentation, keratoses), increased cancer risk (skin, lung, bladder), cardiovascular damage. Causes include contaminated well water, high rice consumption (especially rice grown in Southern U.S.), pesticide exposure, and pressure-treated wood.
Cadmium is a toxic heavy metal that accumulates primarily in the kidneys and liver with a biological half-life of 10–30 years. It disrupts zinc-dependent enzymes and causes oxidative damage to tissues.
To detect chronic cadmium exposure, which causes progressive kidney damage, bone demineralization, and increases cancer risk.
| Category | Value (mcg/L) | Interpretation |
|---|---|---|
| Quest Diagnostics Range | 0–6.5 | Within reference range |
| Elevated | >6.5 | Significant exposure; investigate and intervene |
Normal cadmium indicates minimal toxic exposure. No specific intervention required.
Kidney damage (proteinuria, decreased GFR), bone loss/osteoporosis, increased risk of kidney, lung, and prostate cancer. Causes include cigarette smoking (single largest source), contaminated food, and industrial exposure.
Calprotectin is a protein released by neutrophils (white blood cells) during intestinal inflammation. It is measured in stool and directly reflects the degree of immune activation within the gut lining.
It non-invasively differentiates inflammatory bowel disease (IBD) from irritable bowel syndrome (IBS), potentially sparing patients from unnecessary colonoscopies.
| Category | Value (mcg/g) | Interpretation |
|---|---|---|
| Normal | <50 | No significant gut inflammation |
| Borderline | 50–120 | Mild inflammation; retest in 4–6 weeks |
| Elevated | >120 | IBD likely; GI referral recommended |
| Significantly Elevated | >250 | Active IBD flare |
Low or normal calprotectin strongly suggests the absence of significant inflammatory bowel disease. Symptoms are more likely functional (IBS) in origin.
Crohn's disease, ulcerative colitis, NSAID use, GI infections, colorectal cancer, diverticulitis. Symptoms include chronic diarrhea, bloody stool, abdominal pain, unintended weight loss, and fatigue.
A panel measuring three classes of antibodies against Candida species. IgM indicates acute or recent infection, IgA reflects mucosal/GI involvement, and IgG suggests chronic or past exposure.
To evaluate for systemic or mucosal candida overgrowth, particularly in patients with unexplained GI symptoms, brain fog, and recurrent yeast issues.
| Antibody Class | Negative | Equivocal | Positive |
|---|---|---|---|
| IgM (Acute) | <1.0 | 1.0–1.4 | >1.4 |
| IgA (Mucosal/GI) | <1.0 | 1.0–1.4 | >1.4 |
| IgG (Chronic) | <1.0 | 1.0–1.4 | >1.4 |
Negative results suggest no significant immune response to Candida. Symptoms are likely attributable to other causes such as SIBO, food sensitivities, or dysbiosis.
Candida overgrowth from antibiotic use, high-sugar diet, immunosuppression, diabetes, chronic stress. Note: a positive IgG alone may reflect past exposure rather than active infection. Symptoms include bloating, brain fog, sugar cravings, fatigue, and recurrent thrush.
The Complete Blood Count with Differential measures the cellular components of blood: red blood cells (RBC), white blood cells (WBC), platelets, hemoglobin, hematocrit, and RBC indices (MCV, MCH, MCHC, RDW). The differential breaks down WBC types: neutrophils, lymphocytes, monocytes, eosinophils, and basophils.
The CBC screens for anemia, infection, immune dysfunction, blood cancers, clotting disorders, and nutritional deficiencies. For men on TRT, the CBC is essential for monitoring hematocrit and hemoglobin — testosterone stimulates erythropoiesis and can cause polycythemia, a potentially dangerous thickening of the blood.
| Measure | Quest Diagnostics Range | Optimal / Functional Range |
|---|---|---|
| WBC | 3.4 – 10.8 x10E3/uL | 5.0 – 8.0 K/μL |
| RBC | 4.14 – 5.80 x10E6/uL | 4.7 – 5.5 M/μL |
| Hemoglobin | 12.6 – 17.7 g/dL | 14.0 – 16.5 g/dL |
| Hematocrit | 37.5 – 51.0% | 40 – 50% (flag >54% on TRT) |
| Platelets | 150 – 379 x10E3/uL | 200 – 300 K/μL |
| MCV | 79 – 97 fL | 85 – 95 fL |
| MCH | 27 – 33 pg | 28 – 32 pg |
| RDW | 11.5 – 14.5% | < 13% |
High hematocrit (>54%) on TRT: polycythemia — requires TRT dose reduction, more frequent injections (smaller doses), or therapeutic phlebotomy. Increases risk of stroke, DVT, and PE. Low WBC: immune suppression, viral infections, bone marrow disorders. High WBC: infection, chronic stress, inflammation, smoking. Low MCV (<80): iron deficiency anemia. High MCV (>100): B12 or folate deficiency. High RDW (>14.5%): mixed anemias, early iron/B12 deficiency, cardiovascular risk marker.
A panel of antibodies that detects autoimmune reactivity to gluten. It includes tissue transglutaminase IgA (tTG-IgA), endomysial antibodies (EMA-IgA), deamidated gliadin peptide antibodies (DGP IgA/IgG), and total IgA. Approximately 83% of people with celiac disease remain undiagnosed.
To screen for celiac disease, which causes villous atrophy and malabsorption — the patient must be consuming gluten for accurate results.
| Marker | Negative | Positive | Notes |
|---|---|---|---|
| tTG-IgA | <4 U/mL | >10 U/mL | Primary screen; 4–10 weak positive |
| EMA-IgA | Negative | Positive | Confirmatory, ~100% specificity |
| DGP IgA | <20 U | ≥20 U | Useful in IgA-deficient patients |
| DGP IgG | <20 U | ≥20 U | Useful in IgA-deficient patients |
| Total IgA | 87–352 mg/dL | — | Low IgA causes false-negative tTG/EMA |
Negative antibodies with adequate IgA levels effectively rules out celiac disease. Low total IgA (<7 mg/dL) can produce false-negative tTG and EMA results — DGP IgG becomes the preferred marker.
Celiac disease (autoimmune reaction to gluten). tTG >10x upper limit is virtually diagnostic without biopsy per ESPGHAN guidelines. Symptoms include diarrhea, bloating, weight loss, iron-deficiency anemia, osteoporosis, dermatitis herpetiformis, neuropathy, fatigue, and brain fog.
The Comprehensive Metabolic Panel is a group of 16 blood tests that provides a broad assessment of metabolic health, including kidney function, liver function, electrolyte balance, blood sugar, and protein status. Markers include: glucose, BUN, creatinine, sodium, potassium, chloride, CO2, calcium, total protein, albumin, globulin, A/G ratio, total bilirubin, alkaline phosphatase (ALP), AST, and ALT.
The CMP serves as a foundational health screen. It detects kidney disease, liver damage, diabetes, electrolyte imbalances, and nutritional deficiencies. For men on TRT or other medications, regular CMP monitoring ensures no adverse effects on liver or kidney function.
| Measure | Quest Diagnostics Range | Optimal / Functional Range |
|---|---|---|
| Fasting Glucose | 65 – 99 mg/dL | 70 – 85 mg/dL |
| BUN | 6 – 24 mg/dL | 10 – 16 mg/dL |
| Creatinine | 0.76 – 1.27 mg/dL | 0.9 – 1.2 mg/dL |
| Sodium | 134 – 144 mEq/L | 138 – 142 mEq/L |
| Potassium | 3.5 – 5.2 mEq/L | 4.0 – 4.5 mEq/L |
| Chloride | 96 – 106 mEq/L | 100 – 104 mEq/L |
| CO2 | 20 – 29 mEq/L | 24 – 27 mEq/L |
| Calcium | 8.7 – 10.2 mg/dL | 9.2 – 10.0 mg/dL |
| Total Protein | 6.0 – 8.5 g/dL | 6.5 – 7.5 g/dL |
| Albumin | 3.5 – 5.5 g/dL | 4.2 – 5.0 g/dL |
| Globulin | 1.5 – 4.5 g/dL | 2.0 – 3.5 g/dL |
| A/G Ratio | 1.2 – 2.2 | 1.5 – 2.0 |
| Total Bilirubin | 0.0 – 1.2 mg/dL | 0.2 – 1.0 mg/dL |
| ALP | 44 – 147 IU/L | 50 – 100 IU/L |
| AST | 0 – 40 IU/L | < 25 IU/L |
| ALT | 0 – 44 IU/L | < 25 IU/L |
Elevated glucose (>100 mg/dL fasting): prediabetes concern; correlate with HbA1c and fasting insulin. Elevated AST/ALT: liver stress from alcohol, medications, NAFLD, or supplements. ALT >26 in men is associated with NAFLD even if "within range." Elevated BUN/creatinine: kidney dysfunction, dehydration, or high-protein diet. Creatinine on TRT may be mildly elevated due to increased muscle mass — not always pathologic. Low albumin: malnutrition, liver disease, chronic inflammation. High calcium (>10.5): hyperparathyroidism, malignancy, vitamin D toxicity.
Coenzyme Q10 is a fat-soluble antioxidant found in every cell's mitochondria, where it plays a central role in the electron transport chain — the final step of cellular energy (ATP) production. Production declines significantly with age.
To assess mitochondrial energy capacity, particularly in patients on statins (which deplete CoQ10), those with fatigue, cardiovascular disease, or age-related decline.
| Category | Value (mg/L) | Interpretation |
|---|---|---|
| Deficient | <0.44 | Clinically significant depletion |
| Quest Diagnostics Range | 0.44–1.64 | Lab reference |
| Optimal | 1.0–3.0 | Functional medicine target |
Statin-induced myopathy (muscle pain/weakness), fatigue, exercise intolerance, brain fog, gum disease, weakened immune function. Causes include statin medications, aging (production drops ~50% by age 50), heart failure, and mitochondrial dysfunction.
High CoQ10 from supplementation is generally safe and not associated with toxicity.
Copper is a trace mineral essential for iron metabolism, connective tissue formation, neurotransmitter synthesis, and antioxidant defense (via superoxide dismutase). It exists in a critical balance with zinc — the copper-to-zinc ratio is often more informative than either value alone.
To evaluate copper status and the copper-zinc ratio, as imbalances contribute to anemia, neuropathy, inflammation, and mood disorders.
| Marker | Quest Diagnostics Range | Optimal |
|---|---|---|
| Serum Copper (males) | 72–166 mcg/dL | 70–110 mcg/dL |
| Copper:Zinc Ratio | — | 0.7–1.0 (ideal) |
Anemia unresponsive to iron, neutropenia, peripheral neuropathy (mimics B12 deficiency), osteoporosis. Causes include excess zinc supplementation (most common), gastric bypass, and Menkes disease (rare).
Oxidative stress, mood instability, anxiety, liver damage, Kayser-Fleischer rings (Wilson disease). Causes include chronic inflammation, estrogen therapy, liver disease, and Wilson disease.
Cortisol is the body's primary stress hormone, produced by the adrenal cortex in response to ACTH stimulation from the pituitary. It follows a diurnal rhythm, peaking in the early morning (6–8 AM) and reaching its nadir at midnight. Morning cortisol is measured to assess the peak of this rhythm and evaluate adrenal function.
Morning cortisol screens for adrenal insufficiency (Addison's disease) and Cushing's syndrome. It is also used to evaluate the HPA axis, chronic stress burden, and cortisol dysregulation that can suppress testosterone, impair thyroid function, disrupt sleep, and promote visceral fat accumulation.
| Measure | Quest Diagnostics Range | Optimal / Functional Range |
|---|---|---|
| Cortisol AM | 4.0 – 22.0 mcg/dL (AM specimen) | 10 – 15 μg/dL |
Adrenal insufficiency (primary or secondary), chronic HPA axis suppression, functional cortisol insufficiency, chronic fatigue syndrome, poor stress tolerance, hypotension, and salt cravings.
Cushing's syndrome or disease, chronic psychological or physiological stress, anxiety disorders, insomnia, visceral fat accumulation, insulin resistance, immune suppression, and accelerated muscle catabolism.
DHEA-S is the sulfated form of DHEA, the most abundant circulating steroid hormone in the body. Produced almost exclusively by the adrenal glands, it serves as a precursor to both testosterone and estrogen. DHEA-S levels peak in the mid-20s and decline steadily with age.
DHEA-S is a marker of adrenal function and overall hormonal reserve. It provides insight into the adrenal contribution to androgen production, stress resilience, immune function, and aging.
| Measure | Quest Diagnostics Range | Optimal / Functional Range |
|---|---|---|
| DHEA-S | Age-dependent: 20–29: 280–640, 30–39: 120–520, 40–49: 95–530, 50–59: 70–310, 60–69: 42–290, 70+: 28–175 mcg/dL | 250 – 400 μg/dL |
Adrenal insufficiency, chronic stress or burnout, aging, fatigue, weakened immunity, reduced libido, depression, and poor wound healing. Often seen alongside elevated cortisol in chronic stress states.
Adrenal tumors, congenital adrenal hyperplasia (CAH), or exogenous DHEA supplementation. Mildly elevated levels are usually not concerning in males.
DHT is the most potent androgen in the male body — 3 to 5 times stronger than testosterone at the androgen receptor. It is produced from testosterone by the enzyme 5-alpha reductase, primarily in the prostate, skin, hair follicles, and liver.
To assess androgenic potency, especially in men with hair loss, BPH symptoms, or those on TRT/5-alpha reductase inhibitors.
| Category | Value (ng/dL) | Interpretation |
|---|---|---|
| Low | <12 | Reduced androgenic activity |
| Quest Diagnostics Range | 12–65 | Lab reference (adult males) |
| Optimal | 30–50 | Balanced androgenic function |
| High | >65 | Androgenic excess — hair loss/prostate concern |
Low libido, erectile dysfunction, reduced facial/body hair, metabolic syndrome, delayed wound healing. Causes include 5-alpha reductase inhibitors (finasteride, dutasteride), hypogonadism, and aging.
Androgenic alopecia (male pattern baldness), benign prostatic hyperplasia (BPH), acne, oily skin, prostate growth. Causes include high 5-alpha reductase activity (genetic), TRT (especially topical), and anabolic steroid use.
Estradiol (E2) is the most potent and prevalent estrogen in the male body. In men, it is produced primarily through aromatization of testosterone by the aromatase enzyme, found in adipose tissue, the brain, and bone. The sensitive or ultrasensitive assay (LC/MS-MS) is required for accurate measurement in males, as standard immunoassays produce unreliable results at lower concentrations.
Estradiol balance is critical for male health. Adequate E2 supports bone density, cardiovascular health, libido, and cognitive function. Both excessively low and high estradiol cause significant symptoms. It is essential to monitor E2 on TRT, as exogenous testosterone increases aromatization.
| Measure | Quest Diagnostics Range | Optimal / Functional Range |
|---|---|---|
| Estradiol (males, sensitive) | 8 – 35 pg/mL | 20 – 30 pg/mL |
Joint pain and stiffness, accelerated bone loss and osteoporosis risk, reduced libido (paradoxically), cognitive decline, fatigue, and poor mood. Often caused by over-use of aromatase inhibitors or very low body fat.
Gynecomastia (breast tissue growth), water retention and bloating, erectile dysfunction, emotional lability, mood swings, and increased body fat. Common causes include obesity, high-dose TRT, liver dysfunction, and alcohol excess.
Ferritin is the primary iron storage protein in the body. Serum ferritin reflects total body iron stores and is the most sensitive and specific early marker of iron deficiency. However, ferritin is also an acute phase reactant, meaning it rises with inflammation, infection, and liver disease independent of iron status.
Ferritin is essential for diagnosing both iron deficiency (with or without anemia) and iron overload (hemochromatosis). Low ferritin is an extremely common and underdiagnosed cause of fatigue, hair loss, restless legs, and poor exercise performance.
| Measure | Quest Diagnostics Range | Optimal / Functional Range |
|---|---|---|
| Ferritin (males) | 30 – 400 ng/mL | 50 – 150 ng/mL |
Iron deficiency (even without frank anemia), fatigue, hair loss, restless legs syndrome, poor exercise tolerance, impaired cognitive function, brittle nails, and pagophagia (ice cravings).
Hereditary hemochromatosis, chronic inflammation (ferritin is an acute phase reactant), liver disease, excessive iron supplementation, and alcohol abuse. Iron overload causes organ damage to the liver, heart, and pancreas.
Fibrinogen is a clotting protein (coagulation factor I) produced by the liver that is converted to fibrin during clot formation. It is both a coagulation factor and an acute-phase inflammatory protein, giving it a dual role in cardiovascular risk.
Elevated fibrinogen increases blood viscosity, promotes clot formation, and indicates systemic inflammation — all of which accelerate atherosclerosis and increase heart attack and stroke risk.
| Measure | Quest Diagnostics Range | Optimal / Functional Range |
|---|---|---|
| Fibrinogen | 200 – 400 mg/dL | 200 – 300 mg/dL |
Liver failure, DIC (disseminated intravascular coagulation), congenital afibrinogenemia, severe malnutrition. Symptoms include bleeding tendency, easy bruising, and poor wound healing.
Chronic inflammation, smoking, obesity, diabetes, infection, autoimmune disease, and aging. Increases blood viscosity, DVT/PE risk, and cardiovascular event probability.
RBC folate measures the concentration of folate stored inside red blood cells, providing a more accurate assessment of long-term folate status than serum folate (which reflects recent intake only). Folate (vitamin B9) is essential for DNA synthesis, methylation, amino acid metabolism, and red blood cell production. It works closely with B12 in the methionine cycle.
Folate deficiency causes megaloblastic anemia, elevated homocysteine (cardiovascular and neurological risk), depression, and impaired DNA repair. RBC folate reflects tissue stores over the preceding 2–3 months.
| Measure | Quest Diagnostics Range | Optimal / Functional Range |
|---|---|---|
| Folate RBC | > 280 ng/mL | 400 – 800 ng/mL |
Megaloblastic anemia, elevated homocysteine (cardiovascular risk), depression, cognitive impairment, and impaired DNA synthesis. Causes include poor dietary intake, malabsorption, alcoholism, MTHFR mutations, and medications (methotrexate, anticonvulsants).
Generally not harmful but may mask B12 deficiency (folate can correct the anemia of B12 deficiency while neurological damage progresses silently). Always check B12 alongside folate.
Free T3 is the unbound, active form of triiodothyronine — the thyroid hormone that actually enters cells and activates nuclear receptors to regulate metabolism, energy production, body temperature, heart rate, and gene expression. Only about 20% of T3 is produced directly by the thyroid; the majority is converted from T4 in peripheral tissues.
Free T3 is the best indicator of cellular thyroid function. A patient can have normal TSH and Free T4 yet still experience hypothyroid symptoms if T4-to-T3 conversion is impaired — making Free T3 essential for complete thyroid assessment.
| Measure | Quest Diagnostics Range | Optimal / Functional Range |
|---|---|---|
| Free T3 | 2.3 – 4.2 pg/mL | 3.0 – 4.0 pg/mL |
Poor T4-to-T3 conversion (selenium, zinc, or iron deficiency), chronic illness (sick euthyroid syndrome), high cortisol, caloric restriction, and chronic inflammation. Symptoms include persistent fatigue despite "normal" TSH, cold hands/feet, brain fog, and weight loss resistance.
Hyperthyroidism, Graves' disease, T3 thyrotoxicosis, or excessive T3 supplementation. Symptoms include anxiety, palpitations, tremor, weight loss, heat intolerance, and insomnia.
Free T4 measures the unbound, bioavailable fraction of thyroxine — the primary hormone produced by the thyroid gland. T4 is a prohormone that must be converted to the active hormone T3 by deiodinase enzymes in peripheral tissues (liver, kidneys, gut). About 80% of circulating thyroid hormone is T4.
Free T4 confirms thyroid hormone production capacity and helps differentiate causes of abnormal TSH. It is essential for monitoring thyroid medication dosing and assessing the thyroid gland's synthetic output.
| Measure | Quest Diagnostics Range | Optimal / Functional Range |
|---|---|---|
| Free T4 | 0.82 – 1.77 ng/dL | 1.0 – 1.5 ng/dL |
Hypothyroidism (primary or central), insufficient thyroid medication dosing, or pituitary dysfunction. Symptoms include fatigue, weight gain, cold intolerance, and cognitive sluggishness.
Hyperthyroidism, Graves' disease, excessive levothyroxine dosing, thyroiditis, or biotin supplement interference with the assay.
Free testosterone is the unbound, biologically active fraction of total testosterone — typically only 2–3% of the total. Unlike bound testosterone, free testosterone can enter cells, bind to androgen receptors, and exert direct physiological effects on muscle, bone, brain, and sexual function.
Free testosterone is often more clinically relevant than total testosterone because a man can have a "normal" total T yet experience hypogonadal symptoms if SHBG is elevated and free T is low. It is essential for accurate assessment of androgen status, especially in aging men, obese patients, or those with liver or thyroid conditions that alter SHBG.
| Measure | Quest Diagnostics Range | Optimal / Functional Range |
|---|---|---|
| Free Testosterone | 35.0 – 155.0 pg/mL (equilibrium dialysis) | 15 – 25 ng/dL (or 2–3% of total) |
The same symptom profile as low total testosterone — fatigue, reduced libido, erectile dysfunction, cognitive decline, and muscle wasting — but can occur even when total testosterone appears normal if SHBG is elevated.
Acne, hair thinning, mood changes, and polycythemia risk. May occur when SHBG is abnormally low (insulin resistance, obesity).
FSH is a gonadotropin hormone produced by the anterior pituitary gland. In men, FSH acts on Sertoli cells in the testes to stimulate and maintain spermatogenesis (sperm production). It works in concert with LH, which stimulates testosterone production.
FSH helps distinguish between primary hypogonadism (testicular failure, where FSH is elevated) and secondary hypogonadism (pituitary/hypothalamic dysfunction, where FSH is low or inappropriately normal). It is essential for fertility assessment and is expected to be suppressed in men on exogenous testosterone.
| Measure | Quest Diagnostics Range | Optimal / Functional Range |
|---|---|---|
| FSH | 1.6 – 8.0 mIU/mL | 2 – 8 mIU/mL |
Secondary hypogonadism, pituitary dysfunction, hypothalamic suppression, or exogenous testosterone use. Low FSH on TRT is expected and confirms HPG axis suppression.
Primary hypogonadism — the testes are failing and the pituitary is producing excess FSH in an attempt to stimulate them. Causes include testicular damage, Klinefelter syndrome, chemotherapy, radiation, and varicocele.
GGT is an enzyme found primarily on the surface of liver cells and bile duct epithelium. It plays a central role in glutathione metabolism — the breakdown and recycling of glutathione, the body's master antioxidant. GGT is one of the most sensitive markers of liver stress.
GGT serves as an early warning for liver stress, bile duct obstruction, alcohol use, oxidative stress, and glutathione depletion. It is more sensitive than AST or ALT for detecting liver dysfunction and is an independent predictor of cardiovascular disease, metabolic syndrome, and all-cause mortality.
| Measure | Quest Diagnostics Range | Optimal / Functional Range |
|---|---|---|
| GGT | 8 – 61 U/L | 10 – 30 U/L |
Possible magnesium or zinc deficiency. Hypothyroidism may also lower GGT. Very low levels are usually not a clinical concern.
Alcohol use (even moderate), liver disease (NAFLD, hepatitis, cirrhosis), bile duct obstruction, oxidative stress, glutathione depletion, medication effects (acetaminophen, statins, NSAIDs), obesity, and metabolic syndrome.
Glutathione is the body's "master antioxidant" — a tripeptide (glutamate, cysteine, glycine) produced in every cell. It neutralizes free radicals, regenerates other antioxidants (vitamins C and E), supports Phase II liver detoxification, and modulates immune function.
To assess the body's antioxidant reserve and detoxification capacity, which declines with age, chronic illness, and toxic exposures.
| Category | Value (umol/L) | Interpretation |
|---|---|---|
| Low | <795 | Depleted; oxidative stress likely |
| Quest Diagnostics Range | 795–1,285 | Lab reference |
| Optimal | Upper quartile of range | Robust antioxidant capacity |
Fatigue, brain fog, frequent illness, poor detoxification, chemical sensitivities, accelerated aging. Causes include chronic illness, heavy metal burden, MTHFR variants, aging, acetaminophen overuse, alcohol, and poor protein intake.
High glutathione is desirable and indicates strong antioxidant defense. Not associated with toxicity.
HbA1c measures the percentage of hemoglobin molecules that have glucose permanently attached to them. Because red blood cells live approximately 90–120 days, HbA1c reflects average blood sugar control over the preceding 2–3 months. It is the gold standard for diagnosing and monitoring diabetes.
HbA1c provides a long-term picture of glycemic control that is not affected by day-to-day fluctuations or fasting status. It is critical for identifying prediabetes, monitoring diabetic control, and assessing metabolic health.
| Measure | Quest Diagnostics Range | Optimal / Functional Range |
|---|---|---|
| HbA1c | < 5.7% normal | 5.7–6.4% prediabetes | ≥ 6.5% diabetes | 4.8 – 5.2% |
Chronic hyperglycemia, insulin resistance, prediabetes, or diabetes. Associated with increased cardiovascular risk, neuropathy, retinopathy, nephropathy, and accelerated aging. Note: can be falsely low with hemolytic anemias or falsely high with iron deficiency.
Homocysteine is a sulfur-containing amino acid produced as an intermediate in the methylation cycle — the conversion of methionine to cysteine. It is recycled back to methionine via B12- and folate-dependent enzymes (particularly MTHFR) or converted to cysteine via B6-dependent pathways. Elevated homocysteine indicates impaired methylation.
Elevated homocysteine is an independent risk factor for cardiovascular disease, stroke, deep vein thrombosis, cognitive decline, Alzheimer's disease, and pregnancy complications. It is a functional marker of B12, folate, and B6 status — one of the most actionable biomarkers available.
| Measure | Quest Diagnostics Range | Optimal / Functional Range |
|---|---|---|
| Homocysteine | 0 – 10.4 umol/L | 6 – 8 μmol/L |
Not clinically significant. Very low homocysteine may be seen with over-supplementation of methyl donors.
Cardiovascular disease risk (endothelial damage, accelerated atherosclerosis), B12 deficiency, folate deficiency, MTHFR mutations (C677T, A1298C), B6 deficiency, kidney disease, and hypothyroidism. Each 5 μmol/L increase is associated with approximately 20% increased cardiovascular risk.
High-sensitivity CRP is a protein produced by the liver in response to systemic inflammation. Unlike standard CRP, the high-sensitivity assay measures very low levels of chronic, smoldering inflammation — the type that drives atherosclerosis, metabolic syndrome, and chronic disease.
hs-CRP is one of the strongest independent predictors of cardiovascular events, adding significant prognostic value beyond the lipid panel. The JUPITER trial proved that elevated hs-CRP independently predicts heart attacks and strokes even when LDL is normal.
| Measure | Value | Interpretation |
|---|---|---|
| Low Risk | < 1.0 mg/L | Optimal |
| Moderate Risk | 1.0 – 3.0 mg/L | Average cardiovascular risk |
| High Risk | > 3.0 mg/L | Elevated cardiovascular risk |
| Optimal (Functional) | < 0.55 mg/L | Minimal systemic inflammation |
Chronic systemic inflammation, increased cardiovascular risk, metabolic syndrome, obesity (visceral fat produces inflammatory cytokines), autoimmune conditions, chronic infections, periodontal disease, sleep apnea, and chronic stress. Values >10 mg/L may indicate acute infection — retest in 2–3 weeks.
IGF-1 is a peptide hormone produced primarily by the liver in response to growth hormone (GH) stimulation. It mediates many of the anabolic effects attributed to growth hormone, including muscle growth, bone formation, tissue repair, and cellular regeneration. Unlike GH, which is released in pulsatile bursts, IGF-1 remains relatively stable throughout the day.
IGF-1 assesses growth hormone sufficiency, recovery capacity, and anabolic potential. It is used to screen for GH deficiency, monitor GH or peptide therapy, and evaluate overall vitality.
| Measure | Quest Diagnostics Range | Optimal / Functional Range |
|---|---|---|
| IGF-1 | Age-dependent: 20–25: 116–358, 26–30: 117–329, 31–35: 115–307, 36–40: 109–284, 41–45: 101–267, 46–50: 94–252, 51–55: 87–238, 56–60: 81–225, 61–65: 75–212, 66–70: 69–200 ng/mL | 150 – 250 ng/mL |
Growth hormone deficiency, poor recovery from exercise or injury, decreased muscle mass, increased body fat, thinning skin, accelerated aging, reduced cognitive function, and impaired sleep quality.
Acromegaly (if GH-producing pituitary adenoma), and theoretical concern for cancer cell proliferation at chronically elevated levels.
Fasting insulin measures the amount of insulin circulating in the blood after an overnight fast. Insulin is a peptide hormone produced by the beta cells of the pancreas that facilitates glucose uptake into cells, regulates blood sugar, and plays a central role in fat storage, protein synthesis, and metabolic signaling.
Fasting insulin is one of the earliest markers of metabolic dysfunction — it rises 10–15 years before fasting glucose or HbA1c become abnormal. Elevated fasting insulin indicates insulin resistance, the root driver of metabolic syndrome, type 2 diabetes, cardiovascular disease, and hormonal imbalances including low testosterone and elevated estrogen.
| Measure | Quest Diagnostics Range | Optimal / Functional Range |
|---|---|---|
| Fasting Insulin | 2.6 – 24.9 μIU/mL | 2 – 6 μIU/mL |
| HOMA-IR (calculated) | — | < 1.0 ideal |
Type 1 diabetes (autoimmune beta cell destruction), late-stage type 2 diabetes with beta cell exhaustion, or prolonged fasting.
Insulin resistance, metabolic syndrome, prediabetes, increased cardiovascular risk, non-alcoholic fatty liver disease (NAFLD), and chronic inflammation. High insulin drives fat storage, suppresses testosterone production, and accelerates aging.
Iodine is a trace element required for thyroid hormone synthesis (T3 and T4). The thyroid gland concentrates iodine at 20–40 times its serum level. Adequate iodine is essential for metabolic rate, neurodevelopment, and reproductive health.
To assess iodine adequacy, as both deficiency and excess impair thyroid function.
| Category | Value (mcg/L) | Interpretation |
|---|---|---|
| Deficient | <52 | Increased risk of hypothyroidism/goiter |
| Quest Diagnostics Range | 52–109 | Within reference range |
| Excessive | >109 | Increased thyroid autoantibody risk |
Goiter, hypothyroidism, fatigue, weight gain, cold intolerance, cognitive impairment. Causes include non-iodized salt use, dairy-free/seafood-free diets, and soil depletion.
Excessive supplementation (kelp/seaweed), iodine-containing contrast dye, amiodarone. Paradoxically can cause either hyperthyroidism or hypothyroidism. Levels >130 mcg/L associated with 5.79x increased risk of thyroid autoantibodies.
This panel measures serum iron (the amount of iron circulating in the blood bound to transferrin), TIBC (Total Iron-Binding Capacity — reflecting transferrin availability), and transferrin saturation (the percentage of transferrin occupied by iron). Together, these markers provide a complete picture of iron transport and availability.
While ferritin reflects iron stores, the iron/TIBC panel reveals how iron is being transported and utilized in real time. It is essential for differentiating iron deficiency anemia from anemia of chronic disease, and for diagnosing iron overload.
| Measure | Quest Diagnostics Range | Optimal / Functional Range |
|---|---|---|
| Serum Iron | 27 – 159 mcg/dL (males) | 85 – 130 mcg/dL |
| TIBC | 250 – 370 μg/dL | 275 – 350 μg/dL |
| Transferrin Saturation | 15 – 55% | 25 – 45% |
Iron deficiency — the body has low circulating iron and is upregulating transferrin production to capture more. Causes include blood loss, poor dietary intake, and malabsorption.
Iron overload (hemochromatosis), chronic inflammation, liver disease, or excessive supplementation. High transferrin saturation above 45% raises concern for hemochromatosis and warrants genetic testing (HFE gene).
Low serum iron + low TIBC + normal/high ferritin — iron is "trapped" in storage by inflammation (hepcidin mechanism).
Lead is a toxic heavy metal with no biological function in the human body. Even low-level exposure causes cumulative damage to the nervous system, kidneys, bones, and cardiovascular system. Lead accumulates in bone with a half-life of 20–30 years. Blood lead reflects recent exposure (half-life ~30 days).
To screen for lead exposure, which disrupts hormone production (including testosterone), impairs neurocognitive function, raises blood pressure, and damages kidneys. Lead is a known endocrine disruptor.
| Measure | CDC / Quest Range | Optimal / Functional Range |
|---|---|---|
| Blood Lead | < 5 μg/dL (CDC reference) | < 2 μg/dL |
Neurotoxicity (cognitive decline, memory loss, neuropathy), hypertension, kidney damage, anemia (lead inhibits heme synthesis), reduced testosterone production, decreased sperm quality, and increased cardiovascular mortality. Sources include old paint, contaminated water (lead pipes), imported goods, and occupational exposure.
Luteinizing hormone (LH) is a gonadotropin produced by the anterior pituitary gland. In males, LH stimulates Leydig cells in the testes to produce testosterone. It is released in a pulsatile fashion and is regulated by the hypothalamic-pituitary-gonadal (HPG) axis via GnRH from the hypothalamus and negative feedback from testosterone and estradiol.
LH is essential for differentiating primary hypogonadism (testicular failure — high LH, low testosterone) from secondary hypogonadism (pituitary/hypothalamic dysfunction — low/normal LH, low testosterone). It also helps evaluate fertility and monitor recovery after TRT cessation.
| Measure | Quest Diagnostics Range | Optimal / Functional Range |
|---|---|---|
| LH (males) | 1.7 – 8.6 mIU/mL | 4.0 – 7.0 mIU/mL |
Primary hypogonadism — the testes are failing and the pituitary is compensating by increasing LH. Causes include Klinefelter syndrome, testicular injury/surgery, radiation, varicocele, aging, and autoimmune orchitis.
Secondary (central) hypogonadism — the pituitary or hypothalamus is not sending adequate signals. Causes include pituitary tumors, head trauma, obesity, opioid use, exogenous testosterone/steroids, stress, and sleep deprivation.
The standard lipid panel measures four core markers: Total Cholesterol, LDL-C (low-density lipoprotein cholesterol), HDL-C (high-density lipoprotein cholesterol), and Triglycerides. Cholesterol is essential for cell membranes, hormone synthesis (including testosterone), bile acid production, and vitamin D synthesis. LDL carries cholesterol to tissues; HDL returns it to the liver for excretion.
The lipid panel is the foundational cardiovascular risk assessment tool. Elevated LDL-C and triglycerides are causally linked to atherosclerosis. HDL is protective. The ratios and patterns are especially important in the context of TRT, which can alter lipid profiles.
| Marker | Quest Diagnostics Range | Optimal / Functional Range |
|---|---|---|
| Total Cholesterol | 100 – 199 mg/dL | 150 – 200 mg/dL |
| LDL-C | 0 – 99 mg/dL | < 100 mg/dL (some experts: <70) |
| HDL-C | >39 mg/dL (males) | > 50 mg/dL |
| Triglycerides | 0 – 149 mg/dL | < 100 mg/dL |
| TG/HDL Ratio | N/A | < 2.0 (insulin sensitivity marker) |
High LDL-C: Increased atherogenic risk, especially if small dense LDL predominates. Low HDL-C: Reduced reverse cholesterol transport, associated with metabolic syndrome. High Triglycerides: Insulin resistance, excess carbohydrate/alcohol intake, and increased VLDL production. High TG/HDL ratio: Strong surrogate for insulin resistance and small dense LDL particles.
Lipoprotein(a) is a genetically determined lipoprotein particle consisting of an LDL-like particle covalently bonded to apolipoprotein(a). Lp(a) is both atherogenic (promotes plaque formation) and thrombogenic (inhibits fibrinolysis by competing with plasminogen). Lp(a) levels are ~90% genetically determined and remain relatively stable throughout life.
Lp(a) is an independent, causal risk factor for atherosclerotic cardiovascular disease, aortic valve stenosis, and stroke. It should be measured at least once in every adult. It is not captured by standard lipid panels and explains residual cardiovascular risk in patients with otherwise optimized lipids.
| Measure | Quest Diagnostics Range | Optimal / Functional Range |
|---|---|---|
| Lp(a) | < 75 nmol/L (desirable) | < 30 nmol/L |
| Lp(a) | > 125 nmol/L (high risk) | Aggressive risk factor modification needed |
2–3x increased risk of heart attack, stroke, and aortic valve disease. Risk is compounded by other cardiovascular risk factors (smoking, hypertension, high LDL, diabetes). Lp(a) is not meaningfully lowered by diet, exercise, or statins.
RBC (red blood cell) magnesium measures the intracellular magnesium concentration, providing a more accurate assessment of total body magnesium status than serum magnesium. Magnesium is a cofactor in over 600 enzymatic reactions, including ATP production, DNA synthesis, muscle contraction, and nerve function. Only ~1% of total body magnesium is in serum, making serum levels a poor indicator.
To accurately assess magnesium status. Serum magnesium can appear normal even in significant deficiency because the body maintains serum levels by pulling from intracellular stores. RBC magnesium reflects tissue-level magnesium status over the preceding 120 days (RBC lifespan).
| Measure | Quest Diagnostics Range | Optimal / Functional Range |
|---|---|---|
| RBC Magnesium | 4.2 – 6.8 mg/dL | 5.5 – 6.5 mg/dL |
Muscle cramps, insomnia, anxiety, heart palpitations, hypertension, insulin resistance, poor testosterone production, headaches, and increased cardiovascular risk. Causes include poor dietary intake, stress (cortisol depletes magnesium), alcohol, proton pump inhibitors, diuretics, and high-sugar diets.
Mercury is a toxic heavy metal that exists in three forms: elemental (inhaled vapor), inorganic (occupational exposure), and organic methylmercury (primarily from fish consumption). Blood mercury primarily reflects methylmercury exposure from diet. Mercury binds to selenium-dependent enzymes, disrupting thyroid function, neurological signaling, and antioxidant defenses.
To assess mercury exposure, particularly in individuals who consume large amounts of fish/seafood. Mercury is a potent neurotoxin and endocrine disruptor that can impair thyroid function, reduce testosterone, and cause cognitive symptoms.
| Measure | Quest / CDC Range | Optimal / Functional Range |
|---|---|---|
| Blood Mercury | < 10.0 μg/L | < 5.0 μg/L |
Neurotoxicity (tremor, memory loss, peripheral neuropathy), thyroid dysfunction (mercury competes with selenium for deiodinase enzymes), kidney damage, immune dysregulation, and cardiovascular effects. Primary source is large predatory fish (tuna, swordfish, shark, king mackerel).
Methylmalonic acid is a metabolic intermediate that accumulates when vitamin B12 is insufficient to convert methylmalonyl-CoA to succinyl-CoA (a step in fatty acid and amino acid metabolism). It is the most specific functional marker of intracellular B12 status, detecting deficiency before serum B12 levels drop below the reference range.
To confirm early or subclinical vitamin B12 deficiency, especially when serum B12 is in the "gray zone" (200–400 pg/mL). MMA is more sensitive and specific than serum B12 alone. Elevated MMA with normal folate distinguishes B12 deficiency from folate deficiency (both cause elevated homocysteine).
| Measure | Quest Diagnostics Range | Optimal / Functional Range |
|---|---|---|
| Methylmalonic Acid (serum) | 87 – 318 nmol/L | < 200 nmol/L |
Functional B12 deficiency, even if serum B12 appears "normal." Leads to impaired myelin synthesis (neuropathy, cognitive decline), megaloblastic anemia, fatigue, and elevated homocysteine (cardiovascular risk). Common in vegans/vegetarians, elderly (reduced intrinsic factor), metformin users, and patients with GI malabsorption.
MTHFR (methylenetetrahydrofolate reductase) is a gene that encodes the enzyme responsible for converting 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate — the active form of folate used in methylation. Two common variants are tested: C677T and A1298C. Mutations reduce enzyme efficiency by 30–70%, impacting methylation, homocysteine metabolism, and neurotransmitter synthesis.
To identify genetic impairment in methylation, which affects homocysteine clearance, DNA repair, neurotransmitter production (serotonin, dopamine, norepinephrine), detoxification, and hormone metabolism. Clinically relevant for patients with unexplained elevated homocysteine, depression, or recurrent pregnancy loss.
| Genotype | Enzyme Activity | Clinical Impact |
|---|---|---|
| C677T Heterozygous (CT) | ~65% activity | Mild reduction; may elevate homocysteine |
| C677T Homozygous (TT) | ~30% activity | Significant; elevated homocysteine, higher CV risk |
| A1298C Heterozygous (AC) | ~80% activity | Mild; usually clinically silent alone |
| A1298C Homozygous (CC) | ~60% activity | Moderate reduction in BH4 production |
| Compound Heterozygous (C677T + A1298C) | ~50% activity | Clinically significant; treat as moderate impairment |
The NMR (Nuclear Magnetic Resonance) LipoProfile uses spectroscopy to directly measure lipoprotein particle number and size, rather than estimating cholesterol content. It quantifies LDL particle number (LDL-P), small dense LDL particles, HDL particle number, and VLDL size. This advanced lipid test reveals the true atherogenic burden that standard lipid panels miss.
LDL particle number (LDL-P) is a stronger predictor of cardiovascular events than LDL-C. Up to 30% of patients have discordant LDL-C and LDL-P — meaning their standard lipid panel may underestimate or overestimate their actual risk. NMR is especially valuable in metabolic syndrome, diabetes, and insulin resistance where small dense LDL particles predominate.
| Marker | Quest/LabCorp Range | Optimal / Functional Range |
|---|---|---|
| LDL-P (particle number) | < 1,000 nmol/L (desirable) | < 1,000 nmol/L |
| Small LDL-P | < 527 nmol/L | < 200 nmol/L |
| LDL Size | > 20.5 nm (Pattern A, large buoyant) | > 21.0 nm |
| HDL-P | > 30.5 μmol/L | > 34 μmol/L |
| LP-IR Score | < 45 (low insulin resistance) | < 25 |
High LDL-P: True elevated atherogenic risk regardless of LDL-C. Pattern B (small dense LDL): 3x more atherogenic than large buoyant LDL — associated with insulin resistance, metabolic syndrome, high TG/low HDL. High LP-IR score: Insulin resistance even before fasting glucose or HbA1c become abnormal.
This test measures the balance between anti-inflammatory omega-3 fatty acids (EPA and DHA) and pro-inflammatory omega-6 fatty acids (primarily arachidonic acid) in red blood cell membranes. The Omega-3 Index measures EPA + DHA as a percentage of total RBC fatty acids. The standard Western diet creates a highly inflammatory omega-6:omega-3 ratio of 15–25:1 (optimal is 2–4:1).
To assess inflammatory balance and cardiovascular risk. The Omega-3 Index is an independent risk factor for sudden cardiac death, coronary heart disease, and cognitive decline. It also reflects the body's capacity to resolve inflammation — critical for recovery, hormone function, and metabolic health.
| Marker | Standard Range | Optimal / Functional Range |
|---|---|---|
| Omega-3 Index (EPA + DHA) | > 3.2% (adequate) | 8 – 12% |
| Omega-6:Omega-3 Ratio | Typical Western: 15–25:1 | 2:1 – 4:1 |
| AA:EPA Ratio | Varies | < 5:1 |
Pro-inflammatory state, increased cardiovascular mortality (Omega-3 Index <4% = highest risk zone), accelerated cognitive decline, poor cell membrane fluidity, impaired hormone receptor signaling, depression/anxiety risk, and poor exercise recovery.
Progesterone is a steroid hormone produced in males primarily by the adrenal glands and in small amounts by the testes. Though often considered a "female" hormone, progesterone plays important roles in male physiology: it is a precursor to testosterone and cortisol, acts as a natural 5-alpha reductase inhibitor (reducing DHT), supports GABA receptor activity (calming effect), and has neuroprotective properties.
To assess adrenal function and hormonal balance in men, especially those on TRT. Progesterone counterbalances estrogen effects, supports prostate health (by opposing estrogen-driven proliferation), and contributes to sleep quality and mood stability.
| Measure | Quest Diagnostics Range | Optimal / Functional Range |
|---|---|---|
| Progesterone (males) | 0.0 – 0.5 ng/mL | 0.3 – 1.2 ng/mL |
Adrenal insufficiency, estrogen dominance symptoms (gynecomastia, water retention), anxiety, insomnia, and impaired stress response. Men on TRT may have suppressed progesterone due to HPG axis suppression.
Prolactin is a peptide hormone produced by the anterior pituitary gland. While known primarily for its role in lactation, prolactin in males modulates immune function, reproductive behavior, and dopamine regulation. Prolactin has a reciprocal relationship with dopamine — dopamine inhibits prolactin release, and elevated prolactin indicates dopamine deficiency.
To evaluate for hyperprolactinemia, which suppresses GnRH and consequently lowers testosterone, LH, and FSH. Elevated prolactin is a common cause of secondary hypogonadism, erectile dysfunction, low libido, and infertility in men. It must be ruled out before starting TRT.
| Measure | Quest Diagnostics Range | Optimal / Functional Range |
|---|---|---|
| Prolactin (males) | 4.0 – 15.2 ng/mL | 5.0 – 10.0 ng/mL |
Mild (15–50 ng/mL): Medications (antipsychotics, SSRIs, PPIs, opioids), hypothyroidism, stress, or idiopathic. Moderate (50–100 ng/mL): Possible microprolactinoma or medication effect. Severe (>100 ng/mL): Likely prolactinoma — MRI of pituitary sella indicated.
PSA is a serine protease enzyme produced exclusively by prostatic epithelial cells. It liquefies semen. PSA leaks into the bloodstream in proportion to prostate volume, inflammation, and cellular disruption. It exists in two forms: free PSA (unbound) and complexed PSA (bound to protease inhibitors). The ratio between these forms helps distinguish benign from malignant causes of elevation.
PSA is the primary screening marker for prostate cancer and is mandatory for monitoring men on testosterone replacement therapy. TRT can modestly increase PSA by stimulating prostate growth (though evidence shows it does not increase prostate cancer risk). A baseline PSA is required before starting TRT.
| Age Group | Quest Diagnostics Range | Monitoring Thresholds |
|---|---|---|
| <40 years | 0.0 – 2.0 ng/mL | PSA >2.5 → further evaluation |
| 40–49 years | 0.0 – 2.5 ng/mL | Rise >0.75 ng/mL/year → concern |
| 50–59 years | 0.0 – 3.5 ng/mL | PSA velocity >0.75/year = red flag |
| 60–69 years | 0.0 – 4.5 ng/mL | Free PSA% <10% → higher cancer risk |
| On TRT | Baseline + expected rise | Rise >1.4 ng/mL in 12 months → urology referral |
Prostate cancer (only 25% of men with PSA 4–10 have cancer on biopsy), benign prostatic hyperplasia (BPH), prostatitis/infection, recent ejaculation (within 48 hours), vigorous exercise (cycling), or urinary retention. PSA density (PSA/prostate volume) and PSA velocity improve specificity.
Reverse T3 is a biologically inactive isomer of triiodothyronine (T3) produced by the alternative deiodination of T4 (by type 3 deiodinase, D3). While T4 → T3 conversion (by D1/D2) produces the active thyroid hormone, T4 → rT3 conversion essentially "deactivates" thyroid hormone. The body uses this pathway as a brake during illness, stress, or caloric restriction to conserve energy.
To detect "euthyroid sick syndrome" or functional hypothyroidism — conditions where TSH and T4 may appear normal but the body is producing excess rT3 instead of active T3. Elevated rT3 with low free T3 results in hypothyroid symptoms despite "normal" standard thyroid labs.
| Measure | Quest Diagnostics Range | Optimal / Functional Range |
|---|---|---|
| Reverse T3 | 9.2 – 24.1 ng/dL | 9 – 18 ng/dL |
| Free T3/rT3 Ratio | N/A (calculated) | > 0.20 (pg/mL ÷ ng/dL) |
Chronic stress/cortisol excess, caloric restriction/dieting, chronic illness, inflammation, iron deficiency, selenium deficiency, liver disease, and certain medications (amiodarone, beta-blockers, lithium). High rT3 blocks T3 receptors, creating cellular hypothyroidism.
SHBG is a glycoprotein produced primarily by the liver that binds and transports sex hormones (testosterone, DHT, and estradiol) in the bloodstream. Approximately 65% of total testosterone is tightly bound to SHBG (biologically inactive), 33% is loosely bound to albumin (bioavailable), and only 1–3% circulates as free testosterone (fully active). SHBG acts as the master regulator of sex hormone bioavailability.
SHBG is critical for interpreting total testosterone results. A man with total testosterone of 600 ng/dL and high SHBG may have less bioavailable testosterone than a man with total testosterone of 400 ng/dL and low SHBG. Without SHBG, total testosterone alone can be misleading.
| Measure | Quest Diagnostics Range | Optimal / Functional Range |
|---|---|---|
| SHBG (males) | 16.5 – 55.9 nmol/L | 25 – 45 nmol/L |
Reduces bioavailable testosterone despite adequate total testosterone. Causes include aging, hyperthyroidism, liver disease, low-calorie diets, excess estrogen, HIV medications, and anticonvulsants. Symptoms mimic low testosterone: fatigue, low libido, erectile dysfunction, loss of muscle mass.
Increases free testosterone but also accelerates testosterone clearance and can increase free estradiol. Causes include obesity, insulin resistance, type 2 diabetes, hypothyroidism, PCOS (females), and anabolic steroid use. Low SHBG is an independent risk factor for metabolic syndrome and type 2 diabetes.
Thyroglobulin antibodies are autoantibodies directed against thyroglobulin, the protein precursor of thyroid hormones (T3 and T4) stored in the thyroid follicles. Their presence indicates autoimmune thyroid disease — the immune system is attacking the thyroid gland's own protein stores.
To screen for and confirm autoimmune thyroid disease (Hashimoto's thyroiditis or Graves' disease). TgAb are found in ~80% of Hashimoto's patients. They also interfere with thyroglobulin measurement (used in thyroid cancer monitoring), making their detection essential for accurate cancer surveillance.
| Measure | Quest Diagnostics Range | Interpretation |
|---|---|---|
| Thyroglobulin Antibodies | 0.0 – 0.9 IU/mL | Within reference range |
| Elevated TgAb | > 0.9 IU/mL | Autoimmune thyroid disease likely |
Hashimoto's thyroiditis (most common cause), Graves' disease, thyroid cancer (some types), and occasionally found in other autoimmune conditions (type 1 diabetes, rheumatoid arthritis). Elevated TgAb with elevated TPO antibodies strongly confirms Hashimoto's.
TMAO is a metabolite produced when gut bacteria convert dietary choline, carnitine, and betaine (found in red meat, eggs, and fish) into trimethylamine (TMA), which is then oxidized to TMAO in the liver by flavin monooxygenase 3 (FMO3). TMAO promotes atherosclerosis by enhancing cholesterol uptake into macrophages and promoting foam cell formation in arterial walls.
TMAO is an emerging cardiovascular risk biomarker that reflects gut microbiome composition and function. Elevated TMAO is independently associated with increased risk of heart attack, stroke, and death — even after adjusting for traditional cardiovascular risk factors.
| Measure | Quest Diagnostics Range | Optimal / Functional Range |
|---|---|---|
| TMAO | < 6.2 μmol/L (low risk) | < 6.2 μmol/L |
| TMAO | 6.2 – 9.9 μmol/L (moderate) | Warrants intervention |
| TMAO | > 10.0 μmol/L (elevated) | Significantly increased CV risk |
Altered gut microbiome (dysbiosis), increased cardiovascular risk, enhanced platelet reactivity (thrombosis risk), accelerated atherosclerosis, kidney dysfunction (TMAO cleared renally), and high intake of carnitine/choline from red meat and processed foods.
Total testosterone measures the combined amount of all testosterone in the blood: free testosterone (1–3%), albumin-bound testosterone (~33%), and SHBG-bound testosterone (~65%). Testosterone is the primary male sex hormone, produced mainly in the Leydig cells of the testes (95%) and adrenal glands (5%). It drives muscle mass, bone density, red blood cell production, fat distribution, libido, mood, cognitive function, and cardiovascular health.
Total testosterone is the first-line screening test for hypogonadism. Confirmed low testosterone (on two morning draws) combined with symptoms is the diagnostic criteria for testosterone deficiency. It must be interpreted alongside SHBG and free testosterone for the complete picture.
| Measure | Quest Diagnostics Range | Optimal / Functional Range |
|---|---|---|
| Total Testosterone | 264 – 916 ng/dL | 600 – 900 ng/dL |
| Note | Must be drawn before 10 AM (diurnal variation: highest in morning) | |
Fatigue, decreased libido, erectile dysfunction, depression, brain fog, loss of muscle mass, increased body fat (especially visceral), decreased bone density, anemia, and reduced motivation. Causes include aging (1–2% decline per year after 30), obesity, diabetes, opioid use, pituitary dysfunction, Klinefelter syndrome, and chronic illness.
Exogenous testosterone use, anabolic steroid abuse, adrenal or testicular tumors (rare), and congenital adrenal hyperplasia. Supraphysiologic levels may increase erythrocytosis risk, acne, hair loss, and sleep apnea.
TPO antibodies are autoantibodies directed against thyroid peroxidase, the key enzyme that catalyzes the iodination and coupling reactions needed to produce T3 and T4 from thyroglobulin. Their presence indicates that the immune system is attacking the thyroid's hormone-producing machinery. TPO antibodies are the most sensitive marker for autoimmune thyroid disease.
TPO antibodies are the primary diagnostic marker for Hashimoto's thyroiditis (found in ~95% of cases) and are also elevated in 50–80% of Graves' disease patients. Elevated TPO antibodies predict future hypothyroidism even when current TSH is normal — they can precede clinical disease by years.
| Measure | Quest Diagnostics Range | Interpretation |
|---|---|---|
| TPO Antibodies | 0 – 34 IU/mL | Within reference range |
| Elevated TPO | > 34 IU/mL | Autoimmune thyroiditis likely |
| Very High TPO | > 500 IU/mL | Active Hashimoto's destruction |
Hashimoto's thyroiditis (most common), Graves' disease, postpartum thyroiditis, and increased risk of progression to overt hypothyroidism (~4.3% per year if TPO+ with normal TSH). Also associated with increased pregnancy complications, depression, and other autoimmune conditions.
TSH is a glycoprotein hormone secreted by the anterior pituitary gland that stimulates the thyroid to produce T4 and T3. It operates via a negative feedback loop: when thyroid hormone levels drop, TSH rises (telling the thyroid to produce more); when thyroid hormones are adequate, TSH decreases. TSH is the most sensitive first-line marker of thyroid dysfunction.
TSH is the gold-standard screening test for thyroid disorders. Even small changes in thyroid hormone levels produce large, amplified changes in TSH, making it the earliest indicator of thyroid dysfunction. It is essential for men's health because thyroid hormones directly affect testosterone production, metabolism, energy, and body composition.
| Measure | Quest Diagnostics Range | Optimal / Functional Range |
|---|---|---|
| TSH | 0.45 – 4.50 μIU/mL | 1.0 – 2.5 μIU/mL |
Hypothyroidism — the thyroid is underproducing and the pituitary is increasing TSH to compensate. Symptoms: fatigue, weight gain, cold intolerance, constipation, brain fog, depression, dry skin, hair loss, elevated cholesterol, and decreased testosterone. Most common cause is Hashimoto's thyroiditis.
Hyperthyroidism — the thyroid is overproducing and the pituitary has suppressed TSH. Symptoms: anxiety, rapid heart rate, weight loss, tremor, heat intolerance, insomnia, and diarrhea. Causes include Graves' disease, toxic nodular goiter, thyroiditis, and excessive thyroid medication.
Uric acid is the final breakdown product of purine metabolism (from dietary sources and cellular turnover). It is filtered by the kidneys, with ~90% reabsorbed. Uric acid has a dual nature: at normal levels it acts as an antioxidant (responsible for ~50% of plasma antioxidant capacity), but at elevated levels it becomes pro-inflammatory, promotes oxidative stress, and crystallizes in joints (gout) and kidneys (stones).
To assess risk for gout, kidney stones, cardiovascular disease, metabolic syndrome, and insulin resistance. Elevated uric acid is an independent risk factor for hypertension, kidney disease, and type 2 diabetes. It is increasingly recognized as a metabolic marker, not just a gout marker.
| Measure | Quest Diagnostics Range | Optimal / Functional Range |
|---|---|---|
| Uric Acid (males) | 3.7 – 8.6 mg/dL | 4.0 – 6.0 mg/dL |
Gout (crystallization in joints at >6.8 mg/dL), kidney stones (uric acid stones), hypertension, insulin resistance, metabolic syndrome, cardiovascular disease, kidney disease, and increased fructose/alcohol intake. TRT can slightly increase uric acid via increased muscle mass and purine turnover.
Reduced antioxidant capacity, possible molybdenum deficiency (cofactor for xanthine oxidase), Fanconi syndrome, or Wilson's disease. Very low levels (<2 mg/dL) may reduce neuroprotection.
Vitamin A (retinol) is a fat-soluble vitamin essential for vision, immune function, skin integrity, gene expression, and reproductive health. It exists in two dietary forms: preformed retinol (animal sources) and provitamin A carotenoids (beta-carotene from plants, which must be converted). Retinol is stored in the liver and transported by retinol-binding protein (RBP).
To assess vitamin A status, especially in men with malabsorption, liver disease, or restrictive diets. Vitamin A is essential for testosterone production, spermatogenesis, and immune function. Both deficiency and excess are clinically significant.
| Measure | Quest Diagnostics Range | Optimal / Functional Range |
|---|---|---|
| Retinol (Vitamin A) | 38.0 – 98.0 mcg/dL | 50 – 80 mcg/dL |
Impaired night vision, dry eyes, immune dysfunction, poor wound healing, reduced testosterone and sperm production, and skin disorders (follicular hyperkeratosis). Causes include malabsorption (celiac, Crohn's, pancreatic insufficiency), liver disease, zinc deficiency (needed for RBP synthesis), and very low-fat diets.
Hypervitaminosis A — hepatotoxicity, bone loss, headaches, skin peeling, and teratogenicity. Typically from excessive supplementation (>10,000 IU/day retinol long-term), not from food sources.
Vitamin B12 is a water-soluble vitamin essential for DNA synthesis, red blood cell formation, myelin (nerve sheath) production, methylation reactions, and homocysteine metabolism. It requires intrinsic factor (produced by gastric parietal cells) for absorption in the terminal ileum. B12 is stored extensively in the liver (2–5 years' worth), so deficiency develops slowly but causes serious neurological damage if untreated.
To screen for B12 deficiency, which causes megaloblastic anemia, peripheral neuropathy, cognitive decline, and elevated homocysteine (cardiovascular risk). Serum B12 alone can be misleading — levels 200–400 pg/mL are a "gray zone" where functional deficiency may exist. Pair with methylmalonic acid (MMA) and homocysteine for accuracy.
| Measure | Quest Diagnostics Range | Optimal / Functional Range |
|---|---|---|
| Vitamin B12 | 211 – 946 pg/mL | 500 – 900 pg/mL |
Megaloblastic anemia (large, immature RBCs), peripheral neuropathy (numbness, tingling), cognitive decline, depression, fatigue, glossitis (swollen tongue), and elevated homocysteine. Causes: pernicious anemia (autoimmune intrinsic factor destruction), veganism, metformin use, PPI use, gastric bypass, celiac disease, and aging (reduced gastric acid).
Vitamin C is a water-soluble antioxidant essential for collagen synthesis, immune function, iron absorption, carnitine production, and neurotransmitter synthesis (dopamine, norepinephrine). Humans cannot synthesize vitamin C (unlike most animals) due to a mutation in the GULO gene, making dietary intake essential. It is the primary water-soluble antioxidant, regenerating vitamin E and protecting against oxidative stress.
To assess vitamin C status in individuals with poor dietary intake, smokers (accelerated depletion), chronic inflammation, or malabsorption. Vitamin C supports adrenal function (highest concentration in adrenal glands), cortisol regulation, and testosterone protection from oxidative damage.
| Measure | Quest Diagnostics Range | Optimal / Functional Range |
|---|---|---|
| Vitamin C (Ascorbic Acid) | 0.4 – 2.0 mg/dL | 1.0 – 2.0 mg/dL |
Impaired collagen synthesis (easy bruising, poor wound healing, gum disease), weakened immunity, fatigue, depression, iron deficiency anemia (impaired absorption), increased oxidative stress, and in severe deficiency: scurvy. Smokers require 35 mg/day more than non-smokers. Stress depletes vitamin C rapidly.
Vitamin D is a fat-soluble secosteroid hormone (not just a vitamin) synthesized in the skin via UVB sunlight exposure and obtained from dietary sources. It is converted in the liver to 25(OH)D (the form measured in blood) and then in the kidneys to active 1,25(OH)₂D (calcitriol). Vitamin D receptors exist in virtually every cell, influencing over 1,000 genes involved in immune regulation, bone metabolism, muscle function, mood, and hormone production.
Vitamin D deficiency is pandemic — affecting an estimated 1 billion people worldwide. It is critical for testosterone production (Leydig cells have vitamin D receptors), immune function, bone health, mood regulation, and cancer prevention. Optimization is foundational for men's health.
| Measure | Quest Diagnostics Range | Optimal / Functional Range |
|---|---|---|
| 25(OH) Vitamin D | 30 – 100 ng/mL | 50 – 80 ng/mL |
| Deficient | < 20 ng/mL | Significantly increased disease risk |
| Insufficient | 20 – 29 ng/mL | Suboptimal — supplementation recommended |
Reduced testosterone production, bone loss (osteopenia/osteoporosis), muscle weakness, depression/seasonal affective disorder, impaired immune function (increased infections, autoimmune risk), increased cardiovascular risk, insulin resistance, and increased cancer risk (colorectal, breast, prostate). Causes include inadequate sun exposure, dark skin, obesity (fat-soluble vitamin sequestered in fat), aging, malabsorption, and northern latitudes.







Individual experiences may vary.
Results vary based on the individual, treatment type, and consistency. Many patients notice enhanced focus and energy within 2–4 weeks, with broader longevity benefits often appearing after 4–8 weeks of consistent use.
No strict regimen is required, though combining treatment with tracking metrics (like sleep or biomarkers) can enhance results. Lifestyle factors help optimize outcomes but are not mandatory.
When prescribed and monitored by a licensed medical professional, biohacking treatments are generally safe for eligible patients. Like any medical therapy, they carry potential risks and side effects (such as mild fatigue or adjustment periods), which is why regular monitoring is used to ensure safety.
Yes. Certain treatments require a prescription from a licensed provider after a medical review of your health history, goals, and (when needed) lab results.

© 2026, TestosteroneShots.com PC
text (323)-283-9219
638 1/2 N Robertson Blvd, West Hollywood, CA 90069
The information and products provided on this website are for educational and wellness purposes only and are not intended to diagnose, treat, cure, or prevent any disease. All treatments require evaluation and approval by a licensed healthcare provider through a telemedicine consultation. Individual results may vary, and products carry potential risks and side effects. Certain products may not be evaluated by the U.S. Food and Drug Administration (FDA) unless explicitly stated. Services are provided by licensed physicians and nurse practitioners in states where they are authorized to practice, including California, Florida, Nevada, and other participating states. This service is not intended for medical emergencies. If you are experiencing an emergency, call 911 or seek immediate medical care. We take reasonable measures to protect personal health information in accordance with applicable privacy laws, including HIPAA. By using this website or its services, you agree to our Terms of Service, Privacy Policy, and Telehealth Consent. You must be 18 years of age or older to use this service.